The company reported $9 million in gross profits for the first half of the year, up 122 percent from last year. Mazor’s net loss this quarter increased from $1.1 million last year to $4.4 million, due to an increase in financing income.
The increased profits are due to an increase in Renaissance robotic spine system globally. Currently, 54 systems are installed, and the company received its first follow-up order from a U.S. hospital corporation during the second quarter.
More Articles on Devices:
12 Spine Devices Receive FDA 510(k) Clearance in July
Bacterin International Names Daniel Goldberger CEO
Stryker Launches 2 Minimally Invasive Spine Devices for Facet Joint Pain
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
